|offLabelAdultGuideSupport=* Indigestion <ref name=NIH>{{cite web | title = Magnesium NIH | url =http://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ }}</ref>
|offLabelAdultGuideSupport=* Indigestion <ref name=NIH>{{cite web | title = Magnesium NIH | url =http://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ }}</ref>
|offLabelAdultNoGuideSupport=* Calcium renal calculus; Prophylaxis <ref>{{cite book | last = Wuthrich | first = Rudolf | title = Urolithiasis : therapy prevention | publisher = Springer | location = S.l | year = 2012 | isbn = 978-3-642-70714-8 }}</ref>
|offLabelAdultNoGuideSupport=* Calcium renal calculus; Prophylaxis <ref>{{cite book | last = Wuthrich | first = Rudolf | title = Urolithiasis : therapy prevention | publisher = Springer | location = S.l | year = 2012 | isbn = 978-3-642-70714-8 }}</ref>
* Constipation
* [[Constipation]].
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
<!--FDA-Labeled Indications and Dosage (Pediatric)-->
|fdaLIADPed======Laxative=====
|fdaLIADPed======Laxative=====
* Children 6 to under 12 years: 1 to 2 tablespoons
* Children 6 to under 12 years: 1 to 2 tablespoons.
* Children 2 to under 6 years: 1 to 3 teaspoons
* Children 2 to under 6 years: 1 to 3 teaspoons.
|offLabelPedGuideSupport=There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
|offLabelPedGuideSupport=* Indigestion <ref name=NIH>{{cite web | title = Magnesium NIH | url =http://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ }}</ref>
* [[Constipation]].
<!--Non–Guideline-Supported Use (Pediatric)-->
|offLabelPedNoGuideSupport=There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
<!--Contraindications-->
|warnings=Use caution if the following conditions coexist.
|warnings=Use caution if the following conditions coexist.
* Kidney disease
* Kidney disease.
* A magnesium-restricted diet
* A magnesium-restricted diet.
* Stomach pain, nausea or vomiting
* Stomach pain, [[nausea]] or [[vomiting]].
* A sudden change in bowel habits that lasts over 2 weeks
* A sudden change in bowel habits that lasts over 2 weeks.
* Ask a doctor or pharmacist before use if you are taking any other drug.
* Ask a doctor or pharmacist before use if you are taking any other drug.
* Antacids may interact with certain prescription drugs ° laxatives may affect how other drugs work, so should be taken 2 or more hours before or after other drugs.
* Antacids may interact with certain prescription drugs ° laxatives may affect how other drugs work, so should be taken 2 or more hours before or after other drugs.
* When using this product as an antacid, it may have a laxative effect.
* When using this product as an antacid, it may have a laxative effect.
* Stop use and ask a doctor if have following symptoms.
Stop use and ask a doctor if ° you have rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition ° You need to use a laxative for more than 1 week ° symptoms last more than 2 weeks.
:* Rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition
:* If pregnant or breast-feeding, ask a health professional before use.
If pregnant or breast-feeding, ask a health professional before use.
|postmarketing======Endocrine metabolic=====
|drugInteractions=* Drug
[[Hypermagnesemia]]
:* Description
|FDAPregCat=D
<!--Use in Specific Populations-->
|useInPregnancyFDA=* '''Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
|useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
Line 78:
Line 71:
<!--Overdosage-->
<!--Overdosage-->
|overdose====Acute Overdose===
|drugBox={{Chembox2
| Verifiedfields = changed
====Signs and Symptoms====
| Watchedfields = changed
| verifiedrevid = 476992492
* Description
| ImageFile = Hydroxid hořečnatý.PNG
| ImageSize =
====Management====
| ImageName = Magnesium hydroxide
| ImageFile1 = Brucitestructure.png
* Description
| ImageSize1 =
| ImageName1 = Magnesium hydroxide
===Chronic Overdose===
| IUPACName = Magnesium hydroxide
| OtherNames = Milk of magnesia
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Magnesium hydroxide is a antacid that is FDA approved for the treatment of saline Laxative and antacid. Common adverse reactions include hypermagnesemia.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Laxative
Relieves occasional constipation; generally produces a bowel movement in 1/2 to 6 hours.
Drink a full glass (8 ounces) of liquid with each dose
Adults and children 12 years and older: 2 to 4 tablespoons
Adults and children 12 years and older: 1 to 3 teaspoons with water, up to 4 times daily
A sudden change in bowel habits that lasts over 2 weeks.
Ask a doctor or pharmacist before use if you are taking any other drug.
Antacids may interact with certain prescription drugs ° laxatives may affect how other drugs work, so should be taken 2 or more hours before or after other drugs.
When using this product as an antacid, it may have a laxative effect.
Stop use and ask a doctor if have following symptoms.
Rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition
If pregnant or breast-feeding, ask a health professional before use.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Magnesium hydroxide Clinical Trials Experience in the drug label.
Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Magnesium hydroxide in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Magnesium hydroxide during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Magnesium hydroxide with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Magnesium hydroxide with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Magnesium hydroxide with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Magnesium hydroxide with respect to specific gender populations.
Race
There is no FDA guidance on the use of Magnesium hydroxide with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Magnesium hydroxide in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Magnesium hydroxide in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Magnesium hydroxide in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Magnesium hydroxide in patients who are immunocompromised.
Administration and Monitoring
Administration
Oral
Monitoring
There is limited information regarding Monitoring of Magnesium hydroxide in the drug label.
IV Compatibility
There is limited information regarding IV Compatibility of Magnesium hydroxide in the drug label.
Overdosage
There is limited information regarding Magnesium hydroxide overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
